PEXRIL Trademark

Trademark Overview


On Thursday, May 5, 1994, a trademark application was filed for PEXRIL with the United States Patent and Trademark Office. The USPTO has given the PEXRIL trademark a serial number of 74520297. The federal status of this trademark filing is ABANDONED - EXPRESS as of Monday, December 11, 1995. This trademark is owned by Teva Pharmaceutical Industries Ltd. The PEXRIL trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparation for the treatment of central nervous system disorders and autoimmune diseases

General Information


Serial Number74520297
Word MarkPEXRIL
Filing DateThursday, May 5, 1994
Status601 - ABANDONED - EXPRESS
Status DateMonday, December 11, 1995
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicespharmaceutical preparation for the treatment of central nervous system disorders and autoimmune diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code8 - Abandoned
Class Status DateWednesday, August 4, 1999
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTeva Pharmaceutical Industries Ltd
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address91010 Jerusalem
IL

Trademark Events


Event DateEvent Description
Monday, December 11, 1995ABANDONMENT - EXPRESS MAILED
Thursday, October 20, 1994LETTER OF SUSPENSION MAILED
Wednesday, October 12, 1994EXAMINER'S AMENDMENT MAILED
Tuesday, September 20, 1994NON-FINAL ACTION MAILED
Friday, September 16, 1994ASSIGNED TO EXAMINER